HCSG HEALTHCARE SERVICES GROUP INC
Services-Nursing & Personal Care Facilities · Nasdaq · SEC CIK 731012 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.0%
TTM net income YoY163.9%
TTM EPS YoY174.1%
Revenue 3-yr CAGR4.0%
Net income 3-yr CAGR50.1%
Margins
Gross margin16.1%
Operating margin—
Net margin5.6%
FCF margin5.7%
EBITDA margin—
Returns
ROE20.4%
ROA12.7%
ROIC (approx.)—
Asset turnover2.27x
Leverage & solvency
Liabilities / assets37.5%
Debt / equity0.00x
Current ratio2.82x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.08x
Accruals ratio-1.0%
Payout ratio—
Capex / revenue0.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $479.60M | $470.81M | $462.77M | $466.68M | $464.34M | $458.49M | $447.66M | $437.81M |
| Cost of revenue | $399.21M | $396.01M | $386.93M | $394.61M | $367.93M | $455.53M | $379.69M | $379.21M |
| Gross profit | $80.39M | $74.79M | $75.83M | $72.07M | $96.41M | $2.96M | $67.97M | $58.60M |
| SG&A expense | $48.45M | $52.59M | $42.00M | $46.20M | $50.54M | $49.16M | $44.97M | $44.82M |
| Pretax income | $33.73M | $31.00M | $34.54M | $28.55M | $57.31M | -$41.89M | $23.89M | $14.80M |
| Income tax | $8.85M | $8.31M | $8.48M | -$2.69M | $14.36M | -$9.52M | $6.67M | $2.88M |
| Net income | $24.88M | $22.70M | $26.06M | $31.24M | $42.95M | -$32.37M | $17.23M | $11.92M |
| EPS (basic) | 0.37 | 0.33 | 0.37 | — | 0.59 | -0.44 | 0.23 | — |
| EPS (diluted) | 0.36 | 0.32 | 0.37 | — | 0.59 | -0.44 | 0.23 | — |
| Weighted avg. shares (diluted) | 69.38M | 69.91M | 71.05M | — | 72.97M | 73.16M | 73.96M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $134.60M | $123.41M | $136.17M | $125.19M | $124.42M | $83.14M | $64.38M | $60.13M |
| Short-term investments | $34.22M | $41.32M | $42.44M | $42.77M | $53.07M | $51.67M | $50.50M | $50.53M |
| Receivables | $309.60M | $292.79M | $299.44M | $281.30M | $288.52M | $292.21M | $337.90M | $330.91M |
| Inventory | $15.53M | $15.84M | — | $16.80M | — | — | — | — |
| Current assets | $582.76M | $568.52M | $601.23M | $576.41M | $580.63M | $532.29M | $574.97M | $556.65M |
| Goodwill | $90.46M | $85.80M | $79.80M | $79.80M | $80.06M | $80.04M | $80.04M | $75.53M |
| Intangibles | $16.86M | $13.11M | $6.32M | $6.96M | $7.61M | $8.26M | $10.02M | $9.44M |
| Total assets | $850.40M | $820.86M | $814.85M | $794.25M | $804.30M | $802.20M | $822.96M | $802.77M |
| Current liabilities | $206.42M | $188.12M | $193.37M | $170.38M | $195.64M | $213.93M | $198.75M | $192.55M |
| Total liabilities | $318.95M | $302.01M | $301.08M | $284.04M | $308.30M | $325.16M | $308.76M | $302.85M |
| Shareholders' equity | $531.45M | $518.84M | $513.77M | $510.21M | $496.00M | $477.04M | $514.20M | $499.93M |
| Shares outstanding | 67.43M | 67.98M | 68.93M | 69.60M | 70.67M | 72.41M | 72.92M | 73.20M |
| Cash flow statement | ||||||||
| Operating cash flow | $30.17M | $21.87M | $43.73M | $17.39M | $71.29M | $28.79M | $27.50M | $36.20M |
| Capital expenditure | $2.07M | $1.63M | $1.40M | $1.38M | $1.34M | $1.36M | $1.74M | $1.43M |
| Free cash flow | $28.10M | $20.24M | $42.33M | $16.01M | $69.96M | $27.43M | $25.76M | $34.78M |
| Investing cash flow | -$7.22M | -$13.76M | -$11.55M | $8.56M | -$2.75M | -$2.35M | -$14.47M | $21.80M |
| Financing cash flow | -$11.70M | -$20.92M | -$26.68M | -$19.60M | -$27.27M | -$7.67M | -$8.78M | -$26.01M |
| Depreciation & amortization | $3.20M | $2.70M | $3.81M | $3.87M | $3.40M | $3.20M | $3.88M | $3.60M |
| Stock-based compensation | $2.94M | $2.82M | $2.76M | $3.12M | $2.60M | $2.54M | $3.74M | $2.34M |
| Share buybacks | $11.74M | $20.93M | $23.96M | $19.60M | $27.27M | $7.67M | $7.04M | $1.01M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.